Hypervigilance and Anxiety are Elevated Among Patients With Laryngeal Symptoms With and Without Laryngopharyngeal Reflux
Open Access
- 26 October 2022
- journal article
- letter
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (11) , 2965-2967.e2
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5T32DK007202, K23 DK125266)
This publication has 10 references indexed in Scilit:
- Distinct Clinical Physiologic Phenotypes of Patients With Laryngeal Symptoms Referred for Reflux EvaluationClinical Gastroenterology and Hepatology, 2022
- An update on current treatment strategies for laryngopharyngeal reflux symptomsAnnals of the New York Academy of Sciences, 2021
- ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux DiseaseAmerican Journal of Gastroenterology, 2021
- Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentationsNeurogastroenterology & Motility, 2021
- Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCTHealth Technology Assessment, 2021
- Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal MeetClinical Gastroenterology and Hepatology, 2020
- Laryngopharyngeal Reflux and Functional Laryngeal Disorder: Perspective and Common Practice of the General Gastroenterologist.2018
- Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal diseaseAlimentary Pharmacology & Therapeutics, 2018
- Patients with refractory reflux symptoms: What do they have and how should they be managed?Neurogastroenterology & Motility, 2015
- Development and validation of the Newcastle laryngeal hypersensitivity questionnaireCough, 2014